title: Effective use of panobinostat in combination with other active agents in myeloma in a novel five-drug combination: Case report and interesting observations.
authors.affiliation: Aureus University School of Medicine, Oranjestad, Aruba.
authors.forename: Archana M
authors.initials: AM
authors.lastname: Rajan
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Francis K
authors.initials: FK
authors.lastname: Buadi
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Vincent
authors.initials: V
authors.lastname: Rajkumar
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D000077767:Panobinostat; D016896:Treatment Outcome
chemical_list: D006877:Hydroxamic Acids; D007211:Indoles; D000077767:Panobinostat